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Cellular and deafness mechanisms 
underlying connexin mutation-
induced hearing loss – a common 
hereditary deafness
Jeffrey C. Wingard and Hong-Bo Zhao*
Department of Otolaryngology, University of Kentucky Medical Center, Lexington, KY, USA
Hearing loss due to mutations in the connexin gene family, which encodes gap junctional 
proteins, is a common form of hereditary deafness. In particular, connexin 26 (Cx26, 
GJB2) mutations are responsible for ~50% of non-syndromic hearing loss, which is the 
highest incidence of genetic disease. In the clinic, Cx26 mutations cause various auditory 
phenotypes ranging from profound congenital deafness at birth to mild, progressive hearing 
loss in late childhood. Recent experiments demonstrate that congenital deafness mainly 
results from cochlear developmental disorders rather than hair cell degeneration and 
endocochlear potential reduction, while late-onset hearing loss results from reduction of 
active cochlear amplification, even though cochlear hair cells have no connexin expression. 
However, there is no apparent, demonstrable relationship between specific changes 
in connexin (channel) functions and the phenotypes of mutation-induced hearing loss. 
Moreover, new experiments further demonstrate that the hypothesized K+-recycling 
disruption is not a principal deafness mechanism for connexin deficiency induced hearing 
loss. Cx30 (GJB6), Cx29 (GJC3), Cx31 (GJB3), and Cx43 (GJA1) mutations can also 
cause hearing loss with distinct pathological changes in the cochlea. These new studies 
provide invaluable information about deafness mechanisms underlying connexin muta-
tion-induced hearing loss and also provide important information for developing new 
protective and therapeutic strategies for this common deafness. However, the detailed 
cellular mechanisms underlying these pathological changes remain unclear. Also, little is 
known about specific mutation-induced pathological changes in vivo and little information 
is available for humans. Such further studies are urgently required.
Keywords: gap junction, non-syndromic hearing loss, cochlear supporting cell,  hair cell,  cochlear development, 
active cochlear amplification, potassium recycling, inner ear
introduction
Gap junctions are intercellular channels that connect the cytoplasm of adjacent cells, providing a 
direct intracellular conduit for intercellular communication. A gap junctional channel is formed by 
two hemichannels; each hemichannel is composed of six subunits (Bennett et al., 1991; Harris, 2001). 
Gap junctions exist in both vertebrates and invertebrates. The gap junction proteins in vertebrates 
are mainly encoded by the connexin gene family, which consists of more than 20 connexin isoforms 
(Willecke et al., 2002), whereas the gap junction proteins in invertebrates are encoded by the unrelated 
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innexin family. Pannexin is an innexin homologous gene and also 
encodes gap junctional proteins in vertebrates (Bruzzone et al., 
2003a; Baranova et al., 2004). However, unlike connexins, pan-
nexins usually form non-junctional membrane channels on the 
cell surface to provide an intracellular–extracellular conduit and 
are considered unable to form integral gap junctional channels 
between cells (Boassa et al., 2007; Penuela et al., 2007; Sosinsky 
et al., 2011).
Unlike typical ion channels (such as K+, Na+, and Ca++ chan-
nels), gap junction channels possess a relatively large pore size 
(~10–15 Å) and can allow passage of ions, cell signaling molecules, 
and small molecules up to ~1.5 kDa (Bennett et al., 1991; Harris, 
2001). This direct intercellular communication pathway plays an 
important role in embryonic and postembryonic development, 
cancer suppression, and many physiological and pathological 
functions. Connexin mutations can cause severe deafness and are 
responsible for most cases (> 50%) of hereditary hearing loss in the 
clinic (Kelsell et al., 1997; Zelante et al., 1997; Denoyelle et al., 1998; 
Estivill et al., 1998; Kelley et al., 1998), indicating that connexin 
gap junctions play a critical role in hearing. Connexin mutations, 
mutation-induced auditory phenotypes, and gap junctional func-
tion in the cochlea have been extensively summarized by previous 
reviews [e.g., Zhao et al. (2006), Castillo and Castillo (2011), and 
Chan and Chang (2014)]. In this review, we mainly focus on the 
pathogenesis and deafness mechanisms underlying this common 
hereditary deafness.
Phenotypes of Cx26 (GJB2)  
Mutation-induced Hearing Loss
Connexin 26 (Cx26, GJB2) mutations are a common genetic cause 
for non-syndromic hearing loss and are responsible for ~50% of 
non-syndromic hearing loss in children (Rabionet et  al., 2000). 
Non-syndromic deafness can be autosomal dominant deafness 
(DFNA, DFN: deafness; A: dominant), autosomal recessive 
deafness (DFNB, B: recessive), or X-linked deafness (DFNX, 
X: X-linked). Each type is numbered in the order in which it was 
described. The majority of Cx26 mutations are recessive (DFNB1) 
but a few are dominant (DFNA3). In the clinic, various symptoms 
and auditory phenotypes are observed. Cx26 mutations can result 
in a mild-moderate to profound sensorineural hearing loss (Zhao 
et al., 2006; Castillo and Castillo, 2011; Chan and Chang, 2014). 
The mutation-induced hearing loss is not always congenital and 
can be late-onset and progressive, starting or occurring in child-
hood (Orzan and Murgia, 2007; Pollak et al., 2007; Gopalarao et al., 
2008; Chan and Chang, 2014). This diversity of clinical appearances 
implies that hearing loss induced by Cx26 mutations has various 
pathological changes and different underlying deafness mechanisms.
Functional Analyses of Cx26 Deafness 
Mutations
To date, more than 100 GJB2 mutations have been identified to 
be associated with deafness [connexins and deafness Web site: 
http://davinci.crg.es/deafness/index.php, and also see Mani et al. 
(2009), Castillo and Castillo (2011), and Chan and Chang (2014)]. 
Functional analyses in transfected cells in vitro reveal a variety 
of pathogenic changes caused by these deafness mutations. (i) 
Most mutants cannot correctly track to the cell surface to form 
functional gap junction channels (Martin et  al., 1999; Choung 
et al., 2002; D’Andrea et al., 2002; Thonnissen et al., 2002; Bruzzone 
et al., 2003b; Wang et al., 2003; Bicego et al., 2006). (ii) Mutants 
can also have dominant or trans-dominant negative effects on 
wild-type (WT) Cx26 and co-expressed Cx30 (Thomas et  al., 
2004; Bicego et al., 2006; Deng et al., 2006; Palmada et al., 2006; 
de Zwart-Storm et al., 2008; Yum et al., 2010; Zhang et al., 2011). 
(iii) Some mutants (e.g., p.M34T) can be correctly synthesized 
and target to the plasma membrane, but cannot form efficient 
intercellular gap junction channels (Skerrett et al., 2004; Bicego 
et al., 2006). (iv) Some mutants retain permeability to ions but 
not to small molecules. For example, the Cx26 p.V84L mutant is 
permeable to ions but is impermeable to IP3 (Beltramello et al., 
2005; Zhang et al., 2005). (v) Some deafness-associated mutants, 
such as p.V84L and p.V95M, can form functional homotypic gap 
junction channels but cannot form functional heterotypic channels 
(Choung et al., 2002; Thonnissen et al., 2002; Bruzzone et al., 2003b; 
Wang et al., 2003), indicating that these mutants may specifically 
impair heterogeneous channels in vivo. A gap junction is formed 
by two hemichannels. Hemichannels can also solely function on 
the cell surface to provide an intracellular–extracellular conduit. 
Connexin hemichannels are usually closed at normal extracellular 
Ca++ level under normal physiological conditions but could be 
opened under some pathological conditions (Bennett et al., 2003; 
Goodenough and Paul, 2003). (vi) Some mutants, e.g., p.G45E, can 
cause abnormal hemichannel activity and opening at the normal 
extracellular Ca++ level leading to cell lysis and death (Stong et al., 
2006; Gerido et al., 2007). (vii) Finally, it has been reported that the 
Cx26 p.R75W mutant can impair gap junctional plaque formation 
and reduce the area of gap junctional plaque and protein levels. The 
reduction is associated with excessive endocytosis with increased 
expression of caveolin 1 and 2 (Kamiya et al., 2014). However, 
except for a few mutations, there is no apparent, demonstrable rela-
tionship between mutation phenotypes and auditory phenotypes. 
There is also no definite relationship between mutation-induced 
specific changes in connexin (channel) functions and phenotypes 
of mutation-induced deafness. This lack of correspondence sug-
gests that mutation-induced hearing loss is not directly determined 
by the mutation-induced pathogenic changes in channel function. 
Other factors, such as compensation and cooperation of other 
co-expressed connexins and in vivo functional impairment, may 
also play important roles in hearing loss.
Connexin expression and Function  
in the Cochlea
Connexin expression and gap junctional function in the inner 
ear have been extensively summarized by previous reviews [e.g., 
Zhao et al. (2006)]. Here, we briefly summarize main findings and 
information relevant to this review.
Connexin expression in the Cochlea
In the cochlea, gap junctions exist extensively in the supporting 
cells in the organ of Corti, the stria vascularis (SV), the spiral 
ligament, the spiral limbus, and other cochlear non-sensory cells 
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and structures (Kikuchi et al., 1995; Forge et al., 2003; Zhao and Yu, 
2006; Liu and Zhao, 2008) (Figure 1). Two independent gap junc-
tional networks have been identified in the inner ear: the epithelial 
gap junctional network between supporting cells in the auditory 
sensory epithelium in the organ of Corti and the connective tissue 
gap junctional network between the connective tissue cells in the 
cochlear lateral wall (Kikuchi et al., 1995). However, there is no 
connexin expression in hair cells (Kikuchi et al., 1995; Zhao and 
Santos-Sacchi, 1999; Zhao and Yu, 2006) or gap junctional coupling 
between outer hair cells (OHCs) and supporting cells (Yu and 
Zhao, 2009) (Figure 1).
Multiple connexin genes, GJB2 (Cx26), GJB6 (Cx30), GJB3 
(Cx31), GJC3 (Cx29), and GJA1 (Cx43), have been identified 
in the cochlea (Figure 1). Cx26 and Cx30 are the predominant 
isoforms and are widely expressed in the epithelial and connective 
tissues in a cell-specific and spatiotemporally complex fashion 
(Kikuchi et al., 1995; Lautermann et al., 1998; Forge et al., 2003; 
Zhao and Yu, 2006; Liu and Zhao, 2008). They are largely co-
localized and can form homotypic and heterotypic/heteromeric 
gap junction channels between native cochlear supporting cells 
with asymmetrical-rectified gating, which allows one-directional 
passage (Zhao, 2000; Zhao and Santos-Sacchi, 2000).
Compared to the extensive expression of Cx26 and Cx30, the 
expression of other connexins in the cochlea is limited (Figure 1). 
Cx31 has been detected in type III fibrocytes in the spiral ligament 
in the cochlear lateral wall (Xia et al., 2000; López-Bigas et al., 2002; 
Forge et al., 2003). Cx29 in the cochlea is expressed on the Schwann 
cells wrapping the spiral ganglion (SG) neurons (Yang et al., 2005; 
FiGuRe 1 | Connexin expression and hypothesized K+-recycling in the 
cochlea. Cx26 and Cx30 co-localized in supporting cells of the organ of Corti, 
the spiral limbus (SLM), the stria vascularis (SV), and fibrocytes of the spiral 
ligament (SPL). Cx31 is localized at type II and IV fibrocytes in the subcentral 
region (SR) below the spiral prominence (SP). Cx43 is expressed in the bone of 
the otic capsule. Cx29 is localized only at the Schwann cells wrapping the 
spiral ganglion neurons in the auditory canal. However, hair cells have no 
connexin expression. Inset: the organ of Corti. CT, cochlear tunnel; DC, Deiters 
cell; HC, Hensen cell; IHC, inner hair cell; IPC, inner pillar cell; OHCs, outer hair 
cells; OPC, outer pillar cell; TM, tectorial membrane; I–V, type I–V fibrocytes. 
Modified from Forge et al. (2003), Cohen-Salmon et al. (2004), Zhao and Yu 
(2006), and Liu and Zhao (2008).
Eiberger et al., 2006; Tang et al., 2006). Using immunofluorescent 
staining, Cx43 (GJA1) was initially reported on bone of the otic 
capsule and on cells lining the inside of the bony wall in adult 
animals (Forge et al., 2003; Suzuki et al., 2003). However, using 
lacZ reporter gene in Cx43 KO mice, it was found that Cx43 was 
highly expressed in the connective tissues and weakly expressed in 
the immature sensory epithelium of the cochlea from embryonic 
day 15.5 to the first week after birth and was almost exclusively 
expressed in the bone of the otic capsule after P8 (Cohen-Salmon 
et al., 2004).
Gap Junctional Function in the Cochlea
The hypothetical functions of gap junctions in the cochlea include 
K+-recycling (Santos-Sacchi and Dallos, 1983; Santos-Sacchi, 1987, 
1991; Kikuchi et  al., 1995; Spicer and Schulte, 1998; Zhao and 
Santos-Sacchi, 1998; Zhao, 2000) (Figure 1), nutrient and energy 
supply (Zhao, 2005; Zhao et  al., 2005), intercellular signaling 
(Beltramello et  al., 2005; Zhang et  al., 2005; Zhao et  al., 2005; 
Gossman and Zhao, 2008), endocochlear potential (EP) gen-
eration (Teubner et al., 2003; Chen et al., 2014), generation and 
maintenance of the unique electrochemical environments of the 
endolymph and perilymph (Cohen-Salmon et al., 2002; Teubner 
et al., 2003; Chen et al., 2014), and participation in active cochlear 
amplification (Yu and Zhao, 2009; Zhu et al., 2013, 2015). Recently, 
it has been reported that gap junction-mediated intercellular com-
munication also plays an important role in epithelial repair in the 
cochlea (Forge et al., 2013; Jagger et al., 2014). Thus, dysfunction of 
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gap junctions or connexin mutations can influence many aspects 
of cochlear function. For more detailed information, see Sections 
“Pathological Changes in the Cochlea in Cx26 Deficient Mice,” 
“Deafness Mechanisms Underlying Cx26 Deficiency Induced 
Hearing Loss,” and “Hearing Loss and Pathological Changes 
Induced by Mutations of Other Connexins.”
Hemichannel Function in the Cochlea
Gap junction hemichannels can also function on the cell sur-
face to provide an intracellular–extracellular conduit. Because 
hemichannels possess a relatively large pore size, they can 
release small molecules, such as ATP, which can subsequently 
activate purinergic P2 receptors to form an extracellular pathway 
for intercellular signaling. Gap junction hemichannels in the 
cochlear sensory epithelium can release ATP and IP3 and thus 
participate in intercellular signaling, control of OHC electromo-
tility, K+-sinking, and gap junctional coupling (Zhao et al., 2005; 
Gossman and Zhao, 2008; Yu and Zhao, 2008; Zhu and Zhao, 
2010, 2012). It has been reported that some deafness-associated 
mutants lose permeability to small biochemical molecules, thus 
impairing intercellular signaling (Beltramello et al., 2005; Zhang 
et al., 2005), or cause abnormal hemichannel activity eventually 
leading to cell lysis and death (Stong et al., 2006; Gerido et al., 
2007). This indicates that gap junctional channels and connexin 
hemichannels may play an important role in cell signaling in 
the cochlea.
However, we recently found that Cx26 knockout or Cx30 
knockout had little effect on ATP release in the cochlea under 
normal physiological conditions, while Panx1 deletion can abolish 
ATP release in the cochlea (Chen et al., 2015). These data suggest 
that pannexin channels rather than connexin hemichannels in 
the cochlea play an important role under normal physiological 
conditions.
Connexin-Specific Function in the Cochlea
Cx26 and Cx30 are predominant connexin isoforms in the cochlea 
(Forge et al., 2003; Zhao and Yu, 2006; Liu and Zhao, 2008). It 
has been found that inner ear gap junctions have strong charge 
selectivity; Cx26 is associated with anionic permeability in the 
cochlea (Zhao, 2005). This result is consistent with previous reports 
that Cx26 channels are permeable to both anionic and cationic 
molecules (Elfgang et al., 1995; Manthey et al., 2001; Beltramello 
et  al., 2003), while Cx30 channels are impermeable to anionic 
molecules (Manthey et al., 2001; Beltramello et al., 2003). Thus, 
Cx26 in the cochlea is mainly responsible for permeability to 
anions and may play an important role in intercellular signaling, 
given that most cell signaling molecules (e.g., IP3, ATP, cAMP, and 
cGMP) are anions. This may be a reason why Cx26 but not Cx30 
mutations induce high-incidence of hearing loss and why Cx30 
knockin cannot restore hearing of Cx26 deficient mice (see Section 
“Hearing Restoration in Connexin Deficient Mice”).
However, functions of other connexins in the cochlea remain 
largely unclear. Cx29 is expressed on the Schwann cells at the 
auditory nerve and Cx43 is expressed in the bone. They may be 
involved in SG neuron activation and bone formation. Cx31 is 
mainly expressed in the type III fibrocytes in the cochlear lateral 
wall (Forge et  al., 2003). Currently, little is known about Cx31 
function in the cochlea, even though Cx31 mutations can also 
induce hearing loss (Liu et  al., 2000; Oh et  al., 2013; and also 
see Section “Hearing Loss and Pathological Changes Induced by 
Mutations of Other Connexins”).
Pathological Changes in the Cochlea in 
Cx26 Deficient Mice
Cx26 and Cx30 are expressed in the cochlea and in the brain. 
However, cochlear implants can restore hearing function in 
connexin mutation-induced hearing loss (Rayess et  al., 2015), 
indicating major pathological changes in the cochlea.
Pathological Changes in the Cochlea in  
Cx26 Knockout Mice
Based on observations in Cx26 deletion mice, pathological 
changes of Cx26 deficiency in the cochlea include (i) cochlear 
developmental disorders, (ii) hair cell and SG neuron degenera-
tion, (iii) EP reduction, and (iv) impairment in active cochlear 
amplification (Cohen-Salmon et al., 2002; Sun et al., 2009; Wang 
et al., 2009; Liang et al., 2012; Zhu et al., 2013, 2015; Chen et al., 
2014).
Cochlear Developmental Disorders in Cx26  
Deficient Mice
In mice, the cochlea shows normal morphology and the cochlear 
tunnel starts to open at postnatal day 5 (P5). By P10, the EP and K+ 
concentration in the endolymph rise to high levels (Ehret, 1976; 
Kraus and Aulbach-Kraus, 1981). Hearing starts around P14 and 
matures at P19–20 (Liang et al., 2012) (Figure 2). Cx26-null mice 
are embryonic lethal due to deficiency of transplacental uptake of 
glucose (Gabriel et al., 1998). Using conditional knockout tech-
niques, it has been found that deletion of Cx26 in the cochlea at 
the embryonic period or P0–1 can cause cochlear developmental 
disorders (Wang et al., 2009; Liang et al., 2012; Chen et al., 2014). 
The tectorial membrane attaches at the inner sulcus cells and the 
under-tectorial-membrane space is lost; the cochlear tunnel is 
also filled (Figure 3A). Recently, we further found that deletion 
of Cx26 expression in the cochlea before P5 can induce cochlear 
developmental disorders with congenital deafness (Chen et al., 
2014). However, with deletion of Cx26 after P5, cochlear develop-
ment proceeded normally, the cochlear tunnel opened normally, 
and hearing remained normal at young ages (Chen et al., 2014) 
(Figures 3 and 4). These data suggest that Cx26 expression in the 
cochlea at the early postnatal development stage (<P5) is critical 
for cochlear postnatal development and maturation.
Cochlear Cell Degeneration in Cx26 Deficient Mice
Cx26 deletion in the cochlea can cause hair cell and SG neuron 
degeneration (Sun et al., 2009; Liang et al., 2012), even though 
hair cells have neither connexin expression (Kikuchi, et al., 1995; 
Zhao and Yu, 2006) nor gap junctional coupling (Zhao and Santos-
Sacchi, 1999; Yu and Zhao, 2009). It has been reported that cell 
degeneration is detectable around P14 (Sun et al., 2009; Wang et al., 
2009). However, substantial hair cell loss is not visible until adult-
hood. Severe cochlear hair cell loss and SG neuron degeneration 
also only occurred in middle and basal turns, i.e., in middle and 
FiGuRe 3 | Cochlear developmental disorders and hearing loss 
induced by deletion of Cx26 in the cochlea at different postnatal 
times. (A) Cochlear development after deletion of Cx26 at P1 and P10. 
White arrows indicate that the cochlear tunnel is filled when Cx26 was 
deleted at P1 but developed normally when Cx26 was deleted at P10. Empty 
triangles indicate lack of the under-tectorial-membrane space; the tectorial 
membrane is attached to the inner sulcus cells following deletion of Cx26 at 
P1. (B) Hearing loss following deletion of Cx26 at different postnatal times. 
The ABR thresholds were measured at P30 and were normalized to that in 
WT mice. Corresponding to cochlear developmental disorders, deletion of 
Cx26 before P5 can induce severe hearing loss. However, hearing remains 
normal in young mice following deletion of Cx26 after P6. Modified from 
Chen et al. (2014).
FiGuRe 2 | Cochlear postnatal development and functional 
maturation in mice. (A) Postnatal development of the cochlea. Arrows 
indicate that the cochlear tunnel starts to open at postnatal day 5 (P5) and 
fully opens at P10. (B) Postnatal developments of endocochlear potential 
(EP) and [K+]. Modified from Hibino et al. (2004). (C) Hearing maturation in 
mice. ABR thresholds dramatically drop at P11–16 and reach normal levels 
around P20. Modified from Liang et al. (2012).
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high frequency regions (Sun et al., 2009; Wang et al., 2009; Liang 
et al., 2012). In addition, functional analyses show that hair cells 
in Cx26 deficient mice developed normally and retained normal 
function (Liang et al., 2012). So far, the mechanism underlying hair 
cell and SG neuron degeneration in Cx26 deficient mice remains 
unclear and needs to be further studied.
EP Reduction in Cx26 Deficient Mice
Endocochlear potential is a positive voltage (+100–120 mV) in 
the cochlear endolymph in the scala media (Figure 1) and is a 
driving force for propelling K+ ions through transduction channels 
in hair cells and producing auditory receptor current and potential. 
Positive EP is required for normal hearing and is generated in the 
cochlear lateral wall by a complex process (Chen and Zhao, 2014; 
Chen et al., 2015). Based on a “two-cell” model, EP generation 
is initiated at fibrocyte cells in the spiral ligament, where Na+/
K+-ATPases and Na+, K+, 2Cl- cotransporters depolarize cells to 
approximately -5 mV. Then, the intermediate cells in the SV are 
consequently depolarized to approximately -5 mV through gap 
junctional coupling, which is formed by Cx26 and Cx30 (Liu and 
Zhao, 2008). Since the apical membrane of the intermediate cells 
have ATP-dependent Kir4.1 K+ channels, this will generate a 110–
120  mV transmembrane potential (Nernst’s K+ equilibrium 
potential) between the intracellular space and the intrastrial 
space, i.e., +115–125 mV in the intrastrial space with respect 
to normal extracellular space. Finally, this positive intrastrial 
potential eventually leads to positive EP (+100–120 mV) in 
the endolymph in the scala media (Chen and Zhao, 2014; 
Chen et al., 2015).
Gap junctional coupling is required for positive EP genera-
tion. Deletion of Cx26 expression in the cochlea can cause EP 
reduction (Cohen-Salmon et al., 2002; Chen et al., 2014; Zhu 
et al., 2015). In comparison with that of WT mice, EP in Cx26 
KO mice was reduced by ~50% (Cohen-Salmon et al., 2002; 
Chen et al., 2014). However, EP remained normal following 
targeted-deletion of Cx26 expression in Deiters supporting 
cells and outer pillar supporting cells (Zhu et al., 2013), which 
are located around OHCs in the cochlear sensory epithelium 
(Figure  1). This indicates that impairment of the cochlear 
sensory gap junction network may have little effect on EP 
generation in the inner ear (Zhu et al., 2013; Chen and Zhao, 
2014; Chen et al., 2015).
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Reduction of Active Cochlear Amplification in  
Cx26 Deficient Mice
Normal hearing relies on active cochlear amplification to 
increase hearing sensitivity and frequency selectivity (Dallos, 
2008; Hudspeth, 2008). Two forms of active cochlear mechanics 
have been proposed: one is prestin-based OHC electromotility; 
another is stereocilium-based hair bundle movement. OHC 
electromotility serves as a major source of active cochlear ampli-
fication in mammals (Brownell et al., 1985; Zheng et al., 2000; 
Ashmore, 2008). We found that Cx26 deficiency in the cochlear 
supporting cells can affect OHC electromotility (Yu and Zhao, 
2009; Zhu et al., 2013, 2015), even though OHCs lack connexin 
expression and gap junctional coupling (Kikuchi, et al., 1995; 
Zhao and Santos-Sacchi, 1999; Zhao and Yu, 2006; Yu and Zhao, 
2009). OHCs in Cx26 deficient mice still retain normal develop-
ment and electromotility (Liang et  al., 2012; Zhu et  al., 2013, 
2015). However, OHC electromotility was shifted (Zhu et  al., 
2013, 2015) and active cochlear amplification as measured by 
distortion product otoacoustic emission (DPOAE) was reduced 
(Zhu et al., 2013, 2015). Currently, detailed mechanisms for how 
connexin deficiency in the cochlear supporting cells influences 
OHC electromotility and eventually reduces active cochlear 
amplification remain unclear. This needs to be further examined 
in future studies.
Hearing Loss and Pathological Changes in  
the Cochlea in Cx26 Deafness Mutation  
Knockin Mice
Currently, more than 100 Cx26 deafness mutations have been 
identified. However, only two Cx26 mutation knockin mouse 
models have been established. One is Cx26 p.R75W mutation 
knockin mouse line (Kudo et al., 2003), and another is Cx26 p.S17F 
knockin mouse line (Schütz et al., 2011).
Cx26 p.R75W knockin mice are viable. Similar to Cx26 knock-
out mice, Cx26 p.R75W transgenic mice displayed congenital 
deafness and cochlear developmental disorders, including filling 
of the cochlear tunnel (Kudo et al., 2003). Cell degeneration is also 
visible (Kudo et al., 2003; Inoshita et al., 2008). However, OHCs 
developed normally and retained normal function, but DPOAE 
was reduced (Inoshita et al., 2008; Minekawa et al., 2009).
For Cx26 p.S17F transgenic mice, homozygous mice are not 
viable, whereas the surviving heterozygous mice show a moderate 
hearing loss. The auditory brainstem response (ABR) threshold 
was increased by ~35 dB sound pressure level (SPL) in these mice, 
and EP was reduced by 20–40% (Schütz et al., 2011).
It should be noted that both p.R75W and p.S17F mutations 
are dominant mutations and cause syndromic hearing loss 
(Richard et al., 1998, 2002). Functional analyses showed that 
p.R75W mutation can target to the plasma membrane forming 
gap junctional plaques between cells, but has no channels func-
tion (Chen et al., 2005; Zhang et al., 2011; Kamiya et al., 2014), 
while p.S17F mutation cannot target to the plasma membrane 
forming functional gap junction channels or hemichannels 
(Richard et  al., 2002; Lee et  al., 2009a). These data further 
demonstrate that mutation-induced pathological changes in 
connexin (channel) function are not directly linked to the final 
auditory phenotypes. These data also suggest that deafness 
mechanism(s) underlying connexin mutation-induced syndro-
mic and non-syndromic hearing loss may be similar.
Deafness Mechanisms underlying Cx26 
Deficiency induced Hearing Loss
Deletion of Cx26 in the cochlea can cause cochlear developmental 
disorders, severe hair cell loss, SG neuron degeneration, and EP 
reduction (Cohen-Salmon et  al., 2002; Kudo et  al., 2003; Sun 
et  al., 2009; Wang et  al., 2009; Liang et  al., 2012; Chen et  al., 
2014). These findings provide invaluable information about 
pathological changes induced by Cx26 deficiency. However, the 
underlying deafness mechanism(s) is still unclear. Several deafness 
mechanisms, such as K+-recycling and Ca++-wave propagation 
hypotheses, have been proposed (Kelsell et al., 1997; Beltramello 
et al., 2005; Zhao et al., 2006). However, Cx26 mutations can cause 
various hearing loss phenotypes ranging from congenital deafness 
to late-onset, progressive hearing loss. Apparently, they have dif-
ferent underlying deafness mechanisms (Liang et al., 2012; Zhu 
et al., 2013, 2015; Chen et al., 2014).
Hypothesized Deafness Mechanism for Cx26 
Deficiency induced Hearing Loss
Hypothesized K+-Recycling Impairment: Not a Principal 
Deafness Mechanism
During acoustic stimulation, K+ ions in the endolymph in the 
scala media flow into hair cells through the mechano-transduction 
channels to generate auditory receptor current and potential. Then, 
K+ ions are pumped out to the extracellular space in the perilymph 
through the hair cell’s lateral wall to restore hair cell function. The 
expelled K+ ions are subsequently sunken by cochlear support-
ing cells and are eventually transported back to the endolymph 
in the scala media via gap junctional pathways (Figure 1). This 
hypothesized function of gap junctional coupling in the inner ear 
was proposed about 30 years ago (Santos-Sacchi and Dallos, 1983; 
Kikuchi et al., 1995). Later, it was further hypothesized that Cx26 
mutations may impair gap junctional coupling and disrupt such 
K+-recycling leading to K+ accumulation in the extracellular space 
near hair cells, thereby eventually damaging hair cells and caus-
ing hearing loss (Kelsell et al., 1997; Zhao et al., 2006). However, 
this hypothesized deafness mechanism lacks direct experimental 
evidence, even though it has been widely referred to. As mentioned 
above, not all Cx26 deafness mutations disrupt permeability of 
gap junction channels to ions; some deafness mutants can retain 
permeability to ions. Moreover, Cx26 mutations can cause vari-
ous phenotypes of hearing loss (Castillo and Castillo, 2011; Chan 
and Chang, 2014), indicating that there are different underlying 
deafness mechanisms. Most importantly, our recent study dem-
onstrates that mice with deletion of Cx26 in the cochlea after birth 
can retain normal hearing at young ages (Chen et al., 2014; Zhu 
et al., 2015) (Figure 4). These new data indicate that K+-recycling 
may not be important for hearing, if Cx26 deficiency disrupts the 
K+-recycling. Or, alternatively, the K+-recycling is important for 
hearing but not impaired by Cx26 deletion due to compensation 
by co-expressed Cx30. In any case, the hypothesized K+-recycling 
disruption cannot be a principal deafness mechanism for Cx26 
deficiency induced hearing loss (Zhu et al., 2015).
FiGuRe 4 | Normal hearing in young Cx26 KO mice after deletion of 
Cx26 after birth. (A,B) Immunofluorescent staining for Cx26 in the cochlea 
in WT and Cx26 KO mice at P30 following deletion of Cx26 at P10. No 
positive labeling is visible in the Cx26 KO mouse. (C) ABR thresholds of WT 
and Cx26 KO mice were measured at P30 and P90 following deletion of 
Cx26 at P10. A green arrow indicates that the ABR threshold in Cx26 KO 
mice at P30 remained normal, even though the expression of Cx26 in the 
cochlea was already deleted [see (B)]. At P90, Cx26 KO mice had a 
significant increase in ABR threshold, displaying hearing loss. **, P < 0.001, 
t-test. Scale bars: 50 μm. Modified from Zhu et al. (2015).
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Hypothesis of Impairment in Propagation of Ca++-Waves 
in the Cochlear Sensory Epithelium
As intercellular channels, gap junctions also play an important role 
in intercellular signaling and propagation of Ca++-waves among 
cells. The spread of Ca++-waves among cells can be enacted by 
the passage of Ca++ and IP3 between cells through gap junctions, 
or by the passage of ATP and IP3 through hemichannels and the 
subsequent activation of P2 purinergic receptors and IP3 receptors 
(Harris, 2001; Gossman and Zhao, 2008). Because the Cx26 deaf-
ness mutant p.R75W can impair the spread of Ca++-waves among 
cells (Beltramello et al., 2005; Yum et al., 2010; Zhang et al., 2011; 
Kamiya et al., 2014), it has been hypothesized that Cx26 deficiency 
may impair Ca++-wave propagation in the cochlea leading to 
hearing loss (Beltramello et  al., 2005). However, it is currently 
unclear how such Ca++-wave propagation in the cochlea is related 
to hearing function and deafness, or whether it physiologically 
occurs in the cochlea. Moreover, it is unclear whether other deaf-
ness mutations can impair such Ca++-wave propagation, since 
some mutants can still form functional gap junctional channels 
permeable to ions (see above). Finally, similar to the K+-recycling 
disruption hypothesis, our recent finding that after deletion of 
Cx26 in the cochlea mice can still retain normal hearing at young 
ages (Chen et al., 2014; Zhu et al., 2015) (Figure 4) indicates that 
Ca++-wave propagation impairment cannot be a principal deafness 
mechanism for Cx26 deficiency induced hearing loss.
Deafness Mechanisms underlying Cx26 
Deficiency induced Congenital Deafness
As mentioned above, mouse models show that deletion of Cx26 at 
birth can cause congenital deafness with cochlear developmental 
disorders, hair cell degeneration, and EP reduction (Wang et al., 
2009; Liang et al., 2012; Chen et al., 2014).
Cell degeneration is Not a Primary Cause for Cx26 
Deficiency Induced Congenital Deafness
In mice, hearing starts at P14 and matures at P19–20. We (Liang 
et al., 2012) found that hearing in Cx26 KO mice is completely 
absent throughout the whole postnatal developmental period. The 
threshold of ABR, which is an auditory evoked potential in the 
brain recorded via electrodes placed on the scalp, was even greater 
than 110  dB SPL, indicating complete hearing loss. However, 
substantial hair cell loss was not visible until adulthood, although 
it has been reported that cell degeneration is detectable at young 
ages (Sun et al., 2009; Wang et al., 2009). Moreover, substantial cell 
degeneration was only visible at the middle and basal turns, i.e., in 
middle and high frequency regions (Sun et al., 2009; Wang et al., 
2009; Liang et al., 2012). However, congenital, complete hearing 
loss occurred throughout the whole frequency range (Liang et al., 
2012). Thus, hair cell loss is not a primary cause for Cx26 deficiency 
induced congenital deafness.
Congenital Deafness is Not Caused by EP Reduction
Endocochlear potential is also reduced in Cx26 KO mice (Cohen-
Salmon et al., 2002; Chen et al., 2014). However, EP reduction is 
not associated with hearing loss in Cx26 KO mice. As mentioned 
above, the ABR threshold in Cx26 KO mice was even greater than 
110 dB SPL, demonstrating complete hearing loss (Liang et al., 
2012; Chen et al., 2014). However, the EP in Cx26 KO mice was 
not completely abolished and had a large variability. In some cases, 
the EP remained even at higher levels (>70 mV; Cohen-Salmon 
et al., 2002; Chen et al., 2014).
Cochlear Developmental Disorders are Associated with 
Congenital Deafness Generation
The congenital deafness in Cx26 KO mice, however, is associated 
with cochlear developmental disorders (Liang et al., 2012; Chen 
et al., 2014) (Figure 3). Deletion of Cx26 in the cochlea before P5 
could cause cochlear developmental disorders, the cochlear tunnel 
was filled, and mice had congenital deafness (Chen et al., 2014). 
However, when Cx26 was deleted after P5, the cochlea displayed 
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normal development, the cochlear tunnel was open as normal, 
and there was no congenital deafness (Chen et  al., 2014; Zhu 
et al., 2015). These data suggest that congenital deafness induced 
by Cx26 deficiency is likely to result from cochlear developmental 
disorders (Figure 3). However, the detailed mechanisms for how 
Cx26 deficiency induces cochlear developmental disorders remain 
unclear.
Deafness Mechanisms underlying Cx26 
Deficiency induced Late-Onset Hearing Loss
Cx26 deficiency can also induce late-onset hearing loss. Using 
an inducible gene knockout technique, we found that deletion 
of Cx26 expression in the cochlea after P5 can induce late-onset, 
progressive hearing loss (Chen et al., 2014; Zhu et al., 2015). Mice 
retained normal hearing before P30. Then, hearing loss became 
apparent and severe at high frequencies (Zhu et al., 2015). This 
progression of hearing loss is similar to late-onset, progressive 
hearing loss observed in DFNA3 and DFNB1 non-syndromic 
deafness patients, who have normal hearing in early life, followed 
by hearing loss starting in childhood (Orzan and Murgia, 2007; 
Pollak et al., 2007; Gopalarao et al., 2008).
This Cx26 conditional KO mouse shows normal cochlear 
development and has no substantial hair cell loss (Zhu et al., 2015). 
EP was significantly reduced. However, the EP reduction was not 
associated with progressive hearing loss (Zhu et al., 2015), indicat-
ing that the EP reduction is also not a determining factor in Cx26 
deficiency induced late-onset hearing loss. However, consistent 
with DPOAE reduction observed in patients (Engel-Yeger et al., 
2002, 2003; Santarelli et al., 2007), the mouse model demonstrated 
a progressive DPOAE reduction, severe at high frequencies; func-
tional analysis also showed that OHC electromotility was shifted 
(Zhu et  al., 2015). These data indicate that late-onset hearing 
loss induced by Cx26 deficiency may result from impairment in 
active cochlear amplification. However, the underlying cellular 
mechanism remains undetermined.
Hearing Loss and Pathological Changes 
induced by Mutations of Other Connexins
In addition to GJB2 (Cx26), multiple connexin genes GJB6 (Cx30), 
GJB3 (Cx31), GJC3 (Cx29), and GJA1 (Cx43), have been identified 
in the cochlea. Mutations of these connexin genes can also cause 
hearing loss, even if they are rare.
Cx30 Mutation-induced Hearing Loss and 
Pathological Changes
Cx30 is a predominant connexin isoform, which is extensively 
co-expressed with Cx26 in the cochlea (Forge et  al., 2003; 
Zhao and Yu, 2006; Liu and Zhao, 2008). Cx30 mutations can 
also induce hearing loss. It has been reported that a 342-kb 
deletion truncating the GJB6 (Cx30) gene is associated with 
non-syndromic hearing loss through either homozygous dele-
tion of Cx30 or digenic inheritance of a Cx30 deletion and a 
Cx26 mutation (Castillo et al., 2002). It has also been reported 
that the Cx30 missense mutation p.T5M at the N-terminus 
is associated with autosomal dominant non-syndromic deaf-
ness (DFNA3), characterized by late-onset, middle to high 
frequency hearing loss (Grifa et al., 1999). Functional analysis 
shows that the Cx30 p.T5M mutation can track to the plasma 
membrane but defective channel activity was observed in dye 
transfer assay (Common et al., 2002; Berger et al., 2014). The 
mutation can also impair permeability to IP3 (Zhang et  al., 
2005).
It has been found that Cx30 p.A40V and p.I248V can also 
cause non-syndromic hearing loss (Yang et al., 2007; Oh et al., 
2013). Wang et al. (2011) reported that Cx30 p.A40V mutation 
could not target to the plasma membrane and accumulated in 
the Golgi body. The mutant also exerted a dominant negative 
effect on both WT Cx30 and Cx26, which impaired gap junction 
formation. However, a recent report (Oh et al., 2013) showed that 
both p.A40V and p.I248V deafness mutations could target to the 
plasma membrane to form gap junctional channels; they were 
permeable to calcium ions, but reduced permeability to propidium 
iodide dye.
Cx30T5M/T5M knockin mice exhibited a mild, but significant 
increase in their hearing thresholds of about 15 dB at all frequen-
cies (Schütz et al., 2010). Western blot analysis showed significantly 
downregulated expression levels of Cx26 and Cx30. However, Cx26 
and Cx30 retained normal distribution patterns. The cochlea and 
EP also developed normally. Electrical coupling, probed by dual 
patch-clamp recordings, was normal. However, transfer of the 
fluorescent tracer calcein between cochlear non-sensory cells was 
reduced (Schütz et al., 2010).
Cx30 knockout mice also show deafness with absence of EP 
(Teubner et al., 2003; Chen et al., 2014). After P18, the cochlear 
sensory epithelium starts to degenerate via cell apoptosis (Sun 
et al., 2009). However, it has been found that Cx26 expression at 
the protein level in this Cx30 KO mouse line also decreased to 
30%. Interestingly, restoration of Cx26 expression in this Cx30 
KO mouse line by knockin of an external Cx26 copy can rescue 
its hearing (Ahmad et al., 2007). Recently, it has been reported 
that a new Cx30 conditional KO mouse line, in which half of 
Cx26 expression is preserved, displays normal hearing (Boulay 
et al., 2013). These data imply that hearing loss in Cx30 KO mice 
may result from the accompanied reduction in Cx26 expression. 
Currently, it is still unclear whether sole Cx30 deletion can induce 
hearing loss.
Cx31 Mutation-induced Hearing Loss and 
Pathological Changes
The Cx31 mutations can cause both recessive and dominant 
non-syndromic hearing loss, characterized by late-onset moder-
ate deafness affecting high frequencies (Liu et al., 2000; Oh et al., 
2013). Functional analyses showed that some deafness mutations 
(e.g., p.V27M, p.V43M, and p.V84I) could target to the plasma 
membrane to form gap junctional plaques but lost permeability 
to dyes and ions (Oh et al., 2013). It has also been reported that 
deafness mutation Cx31 p.V174M cannot target to the plasma 
membrane and accumulated in the lysosomes in the mutant-
transfected HeLa cells (Li et  al., 2014). The mutant could also 
impair Cx26 WT intracellular trafficking to the plasma membrane, 
but did not influence trafficking of Cx31 WT (Li et al., 2014). Cx31 
deficiency in mice causes transient placental dysmorphogenesis 
but does not impair hearing (Plum et al., 2001).
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Cx29 Mutation-induced Hearing Loss and 
Pathological Changes
Cx29 mutations can also cause non-syndromic hearing loss (Hong 
et al., 2010a; Wang et al., 2010). Cx29 KO could result in delay 
in maturation of hearing threshold, severe loss of myelination, a 
prolongation in latency and distortion in the wave I of the ABR, 
loss of high frequency sensitivity, and increased sensitivity to noise 
damage (Tang et al., 2006). However, a study from another group 
showed that deletion of Cx29 had no effect on hearing (Eiberger 
et al., 2006). The reason for these conflicting results is currently 
unclear.
Cx43 Mutation-induced Hearing Loss and 
Pathological Changes
Cx43 (GJA1) mutations were also initially linked to non-
syndromic autosomal recessive deafness (Liu et  al., 2001). 
However, it is now clear that the mutations are located in 
the GJA1 pseudogene rather than in GJA1 (Paznekas et  al., 
2003; Hong et al., 2010b). Recently, a new study (Kim et al., 
2013) reported that immunofluorescent staining for Cx43 
showed strong labeling in the mid-internal auditory canal in 
the modiolus, which represents the transition zone between 
Schwann cells and oligodendrocytes. Young Cx43 heterozygous 
mice (3–4  months old) showed mild-moderate hearing loss 
(Kim et al., 2013). The hearing loss became severe when the 
mice were old.
Connexin expression and Pathogenesis  
in the Human Cochlea
Despite extensive studies of connexin expression in the animal 
cochlea (Kikuchi et al., 1995; Forge et al., 2003; Zhao and Yu, 2006; 
Liu and Zhao, 2008), little is known about connexin expression 
in the human inner ear. It has been reported that Cx26 and Cx30 
in the human cochlea have similar expression patterns to animals 
(Liu et al., 2009). Recently, by use of the human fetal cochlea, it 
has been found that the expression of Cx26 and Cx30 is detect-
able in the outer sulcus cells, but not in the spiral ligament in 
the cochlear lateral wall at 18 weeks of gestation (Locher et al., 
2015). However, because of the very limited availability of samples, 
connexin expression in the human cochlea still remains largely 
undetermined.
Moreover, although there are numerous clinical reports of 
connexin mutation-associated hearing loss, there is little descrip-
tion of the pathological changes in humans. Studies of human 
temporal bone CT imaging showed that approximately 50% of 
ears of subjects with GJB2 mutations have temporal bone anomaly 
(Propst et al., 2006; Lee et al., 2009b). Few studies on the patho-
genesis of Cx26 mutations have been done. So far, there is only 
one case-report of a patient that had Cx26 p.G35delG mutation 
and p.E101G missense mutation with profound hearing loss (Jun 
et al., 2000). Microscopic observation revealed nearly complete 
degeneration of hair cells and agenesis of the SV but no neural 
degeneration. However, other factors, such as aging, cannot be 
excluded as contributors to these pathological changes. Further 
studies are needed to define the mutation-associated pathological 
changes in the human cochlea.
Hearing Restoration in Connexin  
Deficient Mice
It has been reported that restoration of Cx26 expression by 
knockin of an external Cx26 copy in the Cx30 KO mouse line 
can rescue its hearing, because the Cx26 expression level in the 
Cx30 KO mice was also dramatically reduced (Ahmad et al., 2007). 
However, Cx30 expression in Cx26 deficient mice was not reduced 
(Zhu et al., 2015), and knockin of an external Cx30 copy in Cx26 
deficient mice cannot rescue hearing (Qu et al., 2012). Unlike 
Cx30 knockin, it has been found that knockin of Cx32 (GJB1) 
in Cx26 deficient mice can restore hearing (Degen et al., 2011). 
As mentioned above (Section “Connexin-Specific Function in 
the Cochlea”), permeability of gap junctions and hemichannels 
in the cochlea is highly charge dependent and Cx26 expression 
is associated with anionic permeability in the cochlea (Zhao, 
2005). Cx26 and Cx30 are predominant connexin isoforms in 
the cochlea (Forge et al., 2003; Zhao and Yu, 2006; Liu and Zhao, 
2008). However, Cx26 channels are permeable to both anionic 
and cationic molecules (Elfgang et al., 1995; Manthey et al., 2001; 
Beltramello et al., 2003), while Cx30 channels are impermeable 
to anionic molecules (Manthey et  al., 2001; Beltramello et  al., 
2003). Thus, Cx26 is able to compensate for Cx30 function, while 
Cx30 cannot completely compensate for Cx26 function. Cx32 is 
similar to Cx26 in that it is permeable to both cationic and anionic 
molecules (Elfgang et al., 1995). This may be a reason why Cx32 
knockin but not Cx30 knockin can restore hearing function in 
Cx26 deficient mice. However, the detailed mechanisms need to 
be further clarified.
Recently, it has also been reported that a genetic approach to 
restore Cx26 expression in the cochlea in Cx26 KO mice after birth 
can preserve both hair cells and SG neurons but cannot restore 
hearing function (Yu et al., 2014). This indicates that restoration 
of hearing function is dependent on not only the level of gene 
expression but also the timing of gene expression.
Summary and Prospection
Cx26 mutations are the major cause of hereditary deafness and can 
induce congenital deafness and late-onset hearing loss (Castillo 
and Castillo, 2011; Chan and Chang, 2014). Connexin-deletion 
mouse models show that congenital deafness induced by Cx26 
deficiency is associated with cochlear developmental disorders 
rather than hair cell loss and EP reduction (Liang et al., 2012; Chen 
et al., 2014), and that late-onset hearing loss induced by Cx26 defi-
ciency results from the reduction of active cochlear amplification 
(Zhu et al., 2013, 2015). The new data also demonstrate that the 
hypothesized K+-recycling disruption is not a principal deafness 
mechanism for Cx26 deficiency induced hearing loss (Chen et al., 
2014; Zhu et al., 2015). These new studies provide a full image of 
deafness mechanisms for Cx26 mutation-induced hearing loss and 
also provide important information for developing new protective 
and therapeutic strategies for this common deafness.
However, the cellular mechanisms underlying Cx26 deficiency 
induced cochlear developmental disorders remain unclear. The 
mechanisms whereby Cx26 deficiency in the supporting cells influ-
ences OHC electromotility and active cochlear amplification are 
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also unclear. Moreover, it is unknown whether specific mutations 
of connexins will produce the same pathological changes as con-
nexin knockout mice. Finally, little is known about pathological 
changes in the human cochlea, and it is unclear whether the 
observed pathological changes in mice are similar to humans.
Creation of specific connexin mutation knockin mouse models 
and investigation of pathological changes in the human cochlea are 
urgently required. The knockin transgenic mice can also provide 
important information about the relationship between mutated 
protein expression and absence of protein expression in  vivo. 
Recently, it has been reported that administration of vitamins A, 
C, and E and magnesium ameliorated progressive hearing loss 
in a child with Cx26 mutation (Thatcher et al., 2014). However, 
the underlying mechanism(s) is not known. These new findings 
further indicate that a more comprehensive understanding of this 
common hereditary deafness is important and urgent and will have 
a tremendous impact on many people, given connexin mutations 
account for more than 50% of hereditary hearing loss.
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